Literature DB >> 21068405

FcR-like 2 Inhibition of B cell receptor-mediated activation of B cells.

Tanisha A Jackson1, Christopher L Haga, Götz R A Ehrhardt, Randall S Davis, Max D Cooper.   

Abstract

FcR-like (FCRL) 2 is a transmembrane protein with immunomodulatory potential that is preferentially expressed by memory B cells in humans. It has two consensus ITIMs in addition to a putative ITAM sequence in its cytoplasmic domain. We have confirmed the cellular distribution of FCRL2 and analyzed its functional potential to show that coligation with the BCR leads to tyrosine phosphorylation of its ITIM motifs and subsequent Src homology region 2 domain-containing phosphatase-1 recruitment to facilitate inhibition of BCR signaling. Mutational analysis indicates that the tyrosine residues in both inhibitory motifs of FCRL2 are required for complete inhibition of BCR signaling, whereas tyrosines in the putative activation motif are dispensable for signal modulation. These findings suggest a negative immunomodulatory function for FCRL2 in the regulation of memory B cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21068405      PMCID: PMC5381824          DOI: 10.4049/jimmunol.1002305

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

Review 1.  Immune inhibitory receptors.

Authors:  J V Ravetch; L L Lanier
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

2.  BXMAS1 identifies a cluster of homologous genes differentially expressed in B cells.

Authors:  Y Nakayama; S M Weissman; A L Bothwell
Journal:  Biochem Biophys Res Commun       Date:  2001-07-20       Impact factor: 3.575

3.  Identification of a family of Fc receptor homologs with preferential B cell expression.

Authors:  R S Davis; Y H Wang; H Kubagawa; M D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

Review 4.  B cell antigen receptor signaling 101.

Authors:  Joseph M Dal Porto; Stephen B Gauld; Kevin T Merrell; David Mills; Aimee E Pugh-Bernard; John Cambier
Journal:  Mol Immunol       Date:  2004-07       Impact factor: 4.407

Review 5.  IgG Fc receptors.

Authors:  J V Ravetch; S Bolland
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

6.  Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia.

Authors:  Maria Ilaria Del Principe; Giovanni Del Poeta; Francesco Buccisano; Luca Maurillo; Adriano Venditti; Antonella Zucchetto; Rita Marini; Pasquale Niscola; Maria Antonietta Irno Consalvo; Carla Mazzone; Licia Ottaviani; Paola Panetta; Antonio Bruno; Riccardo Bomben; Giovanna Suppo; Massimo Degan; Valter Gattei; Paolo de Fabritiis; Maria Cantonetti; Francesco Lo Coco; Domenico Del Principe; Sergio Amadori
Journal:  Blood       Date:  2006-04-06       Impact factor: 22.113

Review 7.  B cell antigen receptor signaling: roles in cell development and disease.

Authors:  Stephen B Gauld; Joseph M Dal Porto; John C Cambier
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

8.  The inhibitory potential of Fc receptor homolog 4 on memory B cells.

Authors:  Gotz R A Ehrhardt; Randall S Davis; Joyce T Hsu; Chuen-Miin Leu; Annette Ehrhardt; Max D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

Review 9.  From pathogenesis to treatment of chronic lymphocytic leukaemia.

Authors:  Thorsten Zenz; Daniel Mertens; Ralf Küppers; Hartmut Döhner; Stephan Stilgenbauer
Journal:  Nat Rev Cancer       Date:  2009-12-03       Impact factor: 60.716

10.  Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment.

Authors:  Christopher L Haga; Götz R A Ehrhardt; Rebecca J Boohaker; Randall S Davis; Max D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-23       Impact factor: 11.205

View more
  24 in total

1.  Involvement of the HCK and FGR src-family kinases in FCRL4-mediated immune regulation.

Authors:  Yanling Liu; Ksenia Bezverbnaya; Tiantian Zhao; Marion J Parsons; Mengyao Shi; Bebhinn Treanor; Götz R A Ehrhardt
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

2.  FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling.

Authors:  Zilu Zhu; Ran Li; Hao Li; Tong Zhou; Randall S Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

Review 3.  Emerging roles for the FCRL family members in lymphocyte biology and disease.

Authors:  F J Li; W J Won; E J Becker; J L Easlick; E M Tabengwa; R Li; M Shakhmatov; K Honjo; P D Burrows; R S Davis
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

4.  CD21(-/low) marginal zone B cells highly express Fc receptor-like 5 protein and are killed by anti-Fc receptor-like 5 immunotoxins in hepatitis C virus-associated mixed cryoglobulinemia vasculitis.

Authors:  Benjamin Terrier; Satoshi Nagata; Tomoko Ise; Michelle Rosenzwajg; Ira Pastan; David Klatzmann; David Saadoun; Patrice Cacoub
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

5.  Age-associated B Cells Appear in Patients with Granulomatous Lung Diseases.

Authors:  Swati Phalke; Katja Aviszus; Kira Rubtsova; Anatoly Rubtsov; Briana Barkes; Linda Powers; Brenda Warner; James L Crooks; John W Kappler; Evans R Fernández-Pérez; Lisa A Maier; Nabeel Hamzeh; Philippa Marrack
Journal:  Am J Respir Crit Care Med       Date:  2020-10-01       Impact factor: 21.405

6.  Ligation of human Fc receptor like-2 by monoclonal antibodies down-regulates B-cell receptor-mediated signalling.

Authors:  Mahdi Shabani; Ali Ahmad Bayat; Mahmood Jeddi-Tehrani; Hodjatallah Rabbani; Mohammad Hojjat-Farsangi; Cristina Ulivieri; Zahra Amirghofran; Cosima Tatiana Baldari; Fazel Shokri
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

7.  FCRL3 promotes TLR9-induced B-cell activation and suppresses plasma cell differentiation.

Authors:  Fu Jun Li; Daniel M Schreeder; Ran Li; Jiongru Wu; Randall S Davis
Journal:  Eur J Immunol       Date:  2013-08-12       Impact factor: 5.532

8.  Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Fas(lpr) mouse.

Authors:  To-Ha Thai; Heide Christine Patterson; Duc-Hung Pham; Katalin Kis-Toth; Denise A Kaminski; George C Tsokos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

9.  Investigation of the human FCRL1, 2, and 4 gene expressions in patients with rheumatoid arthritis.

Authors:  Ali Khanzadeh; Zahra Habibagahi; Ahmad Hosseini; Zahra Amirghofran
Journal:  Rheumatol Int       Date:  2016-05-18       Impact factor: 2.631

10.  Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptors.

Authors:  Andrea Franco; Bazarragchaa Damdinsuren; Tomoko Ise; Jessica Dement-Brown; Huifang Li; Satoshi Nagata; Mate Tolnay
Journal:  J Immunol       Date:  2013-04-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.